Shah, A., Finkelman, B., Gerratana, L., Davis, A., Katam, N., Lin, C., … Cristofanilli, M. (2020). ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing. In Journal of Clinical Oncology (Vol. 38). Chicago, IL: American Society of Clinical Oncology.

Shah, Ami, Brian Finkelman, Lorenzo Gerratana, Andrew Davis, Neelima Katam, Chenyu Lin, Kristen Carroll, et al. “ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing.” In Journal of Clinical Oncology, Vol. 38. American Society of Clinical Oncology, 2020.

Shah A, Finkelman B, Gerratana L, Davis A, Katam N, Lin C, et al. ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing. In: Journal of Clinical Oncology. American Society of Clinical Oncology; 2020.

Shah, Ami, et al. “ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing.” Journal of Clinical Oncology, vol. 38, no. 15_suppl, American Society of Clinical Oncology, 2020.

Shah A, Finkelman B, Gerratana L, Davis A, Katam N, Lin C, Carroll K, Jacob S, Wehbe F, Gurley M, Lin F, Blanco L, Vagia E, Platanias L, Gradishar W, Behdad A, Cristofanilli M. ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing. Journal of Clinical Oncology. American Society of Clinical Oncology; 2020.